Prehospital critical care drug-therapy and 30-day mortality in patients with acute respiratory disease

doi:10.5847/wjem.j.1920-8642.2025.008

Abstract

Abstract:

BACKGROUND Prehospital medication is a reality, and the role of these therapies must be explored to assess their validity, especially for acute respiratory diseases, which are usually associated with increased morbidity. The aim of this study was to examine the association of prehospital medication use with mortality in patients with acute respiratory disease.

METHODS: A prospective, multicenter, emergency medical service (EMS) delivery cohort study was carried out in adults with unselected respiratory diseases managed by EMS who were transferred to the emergency department. From January 1, 2019, to October 31, 2023, six advanced life support units, thirty-eight basic life support units, and four hospitals in Spain participated in the study. Demographic data, vital signs, use of mechanical ventilation, prehospital respiratory diagnosis, and prehospital medication were collected. The primary outcome was 30-day in-hospital mortality.

RESULTS: A total of 961 patients were included, with a mortality rate of 17.5% (168 patients). Age, an increasing number of comorbidities, the use of invasive mechanical ventilation (IMV), the use of major analgesics, hypnotics, and bicarbonate were risk factors. In contrast, elevated systolic blood pressure and Glasgow Coma Scale scores were found to be protective factors against mortality. The predictive capacity of the model reached an area under the curve (AUC) of 0.857 (95% confidence interval [95% CI] 0.827-0.888).

CONCLUSION: Our data revealed that IMV, major analgesics, hypnotics and bicarbonate administration were associated with elevated mortality. Adding prehospital drug therapy information to demographic variables and vital signs could improve EMS decision-making, allowing a better characterization of patients at risk of clinical worsening.

Key words: Drug-therapy, Medication, Prehospital, Mortality, Emergency medical services

Jesús Jurado-Palomo, José Luis Martín-Conty, Begoña Polonio-López, Cristina Rivera Picón, Raúl López-Izquierdo, Carlos del Pozo Vegas, Pedro Ángel de Santos Castro, Ancor Sanz-García, Francisco Martín-Rodríguez. Prehospital critical care drug-therapy and 30-day mortality in patients with acute respiratory disease[J]. World Journal of Emergency Medicine, 2025, 16(1): 43-50.

Figures/Tables 6

Figure 1.

Figure 2.

Table 1.

Table 2.

Table 3.

Table 4.

References 30

1	Afzali F, Jahani Y, Bagheri F, Khajouei R. The impact of the emergency medical services (EMS) automation system on patient care process and user workflow. BMC Med Inform Decis Mak. 2021; 21(1): 292.
2	Hodroge SS, Glenn M, Breyre A, Lee B, Aldridge NR, Sporer KA, et al. Adult patients with respiratory distress: current evidence-based recommendations for prehospital care. West J Emerg Med. 2020; 21(4): 849-57. doi: 10.5811/westjem.2020.2.43896 pmid: 32726255
3	Jouffroy R, Gilbert B, Tourtier JP, Bloch-Laine E, Ecollan P, Bounes V, et al. Impact of prehospital antibiotic therapy on septic shock mortality. Prehosp Emerg Care. 2021; 25(3): 317-24.
4	Esteves AM, Gilchrist HE, Markwood JM, Bondurant M, Roginski MA. Evaluation of nonintubated analgesia practices in critical care transport. Air Med J. 2023; 42(4): 259-62. doi: 10.1016/j.amj.2023.03.006 pmid: 37356886
5	Alam N, Oskam E, Stassen PM, van Exter P, van de Ven PM, Haak HR, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2018; 6(1): 40-50. doi: 10.1016/S2213-2600(17)30469-1 pmid: 29196046
6	Jones J, Allen S, Davies J, Driscoll T, Ellis G, Fegan G, et al. Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe). Sci Rep. 2021; 11(1): 18586. doi: 10.1038/s41598-021-97979-w pmid: 34545117
7	Vallentin MF, Granfeldt A, Meilandt C, Povlsen AL, Sindberg B, Holmberg MJ, et al. Effect of intravenous or intraosseous calcium vs. saline on return of spontaneous circulation in adults with out-of-hospital cardiac arrest: a randomized clinical trial. JAMA. 2021; 326(22): 2268-76. doi: 10.1001/jama.2021.20929 pmid: 34847226
8	Baggott C, Hardy JK, Sparks J, Sabbagh D, Beasley R, Weatherall M, et al. Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis. Thorax. 2022; 77(6): 563-72.
9	Ferrando-Vivas P, Doidge J, Thomas K, Gould DW, Mouncey P, Shankar-Hari M, et al. Prognostic factors for 30-day mortality in critically ill patients with coronavirus disease 2019: an observational cohort study. Crit Care Med. 2021; 49(1):102-11. doi: 10.1097/CCM.0000000000004740 pmid: 33116052
10	Kunisaki KM, Dransfield MT, Anderson JA, Brook RD, Calverley PMA, Celli BR, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial. Am J Respir Crit Care Med. 2018; 198(1): 51-7.
11	Saleem N, Kulkarni A, Snow TAC, Ambler G, Singer M, Arulkumaran N. Effect of corticosteroids on mortality and clinical cure in community-acquired pneumonia: a systematic review, meta-analysis, and meta-regression of randomized control trials. Chest. 2023; 163(3): 484-97.
12	Muiser S, Imkamp K, Seigers D, Halbersma NJ, Vonk JM, Luijk BHD, et al. Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD. Thorax. 2023; 78(5): 451-8. doi: 10.1136/thorax-2022-219620 pmid: 36725331
13	Fishe JN, Garvan G, Bertrand A, Burcham S, Hendry P, Shah M, et al. Early Administration of steroids in the ambulance setting: an observational design trial (EASI-AS-ODT). Acad Emerg Med. 2024; 34(1): 49-60.
14	Hong B, Merrill KA, Golding MA, Simons E, Ben-Shoshan M, Protudjer JLP. Prehospital epinephrine administration for treating anaphylaxis among those with comorbid asthma: a scoping review. Ann Allergy Asthma Immunol. 2023; 131(1): 69-74.e1.
15	Huabbangyang T, Silakoon A, Sangketchon C, Sukhuntee J, Kumkong J, Srithanayuchet T, et al. Effects of pre-hospital dexamethasone administration on outcomes of patients with COPD and asthma exacerbation; a cross-sectional study. Arch Acad Emerg Med. 2023; 11(1): e56. doi: 10.22037/aaem.v11i1.2037 pmid: 37671276
16	Patrick C, Ward B, Anderson J, Rogers Keene K, Adams E, Cash RE, et al. Feasibility, effectiveness and safety of prehospital intravenous bolus dose nitroglycerin in patients with acute pulmonary edema. Prehosp Emerg Care. 2020; 24(6): 844-50.
17	Michelet F, Smyth M, Lall R, Noordali H, Starr K, Berridge L, et al. Randomised controlled trial of analgesia for the management of acute severe pain from traumatic injury: study protocol for the paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN). Scand J Trauma Resusc Emerg Med. 2023; 31(1): 84.
18	Hutchings C, Yadav K, Cheung WJ, Young T, Sikora L, Eagles D. A systematic review of sufentanil for the management of adults with acute pain in the emergency department and pre-hospital setting. Am J Emerg Med. 2023; 70: 10-8. doi: 10.1016/j.ajem.2023.04.020 pmid: 37186978
19	Acquisto NM, Mosier JM, Bittner EA, Patanwala AE, Hirsch KG, Hargwood P, et al. Society of Critical Care Medicine clinical practice guidelines for rapid sequence intubation in the critically ill adult patient. Crit Care Med. 2023; 51(10): 1411-30. doi: 10.1097/CCM.0000000000006000 pmid: 37707379
20	Price J, Moncur L, Lachowycz K, Major R, Sagi L, McLachlan S, et al. Predictors of post-intubation hypotension in trauma patients following prehospital emergency anaesthesia: a multi-centre observational study. Scand J Trauma Resusc Emerg Med. 2023; 31(1): 26.
21	National Heart L, Moss M, Huang DT, Brower RG, Ferguson ND, Ginde AA, et al. Early neuromuscular blockade in the acute respiratory distress syndrome. N Engl J Med. 2019; 380(21): 1997-2008.
22	Ramsey JT, Pache KM, Sayre MR, Maynard C, Johnson NJ, Counts CR. Comparison of intubating conditions with succinylcholine versus rocuronium in the prehospital setting. Prehosp Emerg Care. 2024; 28(4):537-44.
23	Zhang ZH, Zhu C, Mo L, Hong YC. Effectiveness of sodium bicarbonate infusion on mortality in septic patients with metabolic acidosis. Intensive Care Med. 2018; 44(11): 1888-95. doi: 10.1007/s00134-018-5379-2 pmid: 30255318
24	Touron M, Javaudin F, Lebastard Q, Baert V, Heidet M, Hubert H, et al. Effect of sodium bicarbonate on functional outcome in patients with out-of-hospital cardiac arrest: a post-hoc analysis of a French and North-American dataset. Eur J Emerg Med. 2022; 29(3): 210-20. doi: 10.1097/MEJ.0000000000000918 pmid: 35297385
25	Martín-Rodríguez F, Sanz-García A, Ortega Moreno L, Del Pozo Vegas C, Castro-Villamor MA, Martín-Conty JL, et al. Risk for early death in acutely ill older adults attended by prehospital emergency medical services. Emergencias. 2020; 32(3): 177-84. pmid: 32395925
26	Lam RPK, Dai Z, Lau EHY, Ip CYT, Chan HC, Zhao L, et al. Comparing 11 early warning scores and three shock indices in early sepsis prediction in the emergency department. World J Emerg Med. 2024; 15(4):273-82. doi: 10.5847/wjem.j.1920-8642.2024.052 pmid: 39050223
27	Shorr AF, Sun XW, Johannes RS, Yaitanes A, Tabak YP. Validation of a novel risk score for severity of illness in acute exacerbations of COPD. Chest. 2011; 140(5): 1177-83. doi: S0012-3692(11)60583-7 pmid: 21527510
28	Hou J, Nehme E, Dawson L, Bloom J, Nehme Z, Okyere D, et al. Epidemiology, outcomes and predictors of mortality in patients transported by ambulance for dyspnoea: a population-based cohort study. Emerg Med Australas. 2023; 35(1):48-55.
29	Martín-Rodríguez F, López-Izquierdo R, Sanz-García A, Ortega GJ, del Pozo Vegas C, delgado-Benito JF, et al. Prehospital Respiratory Early Warning Score for airway management in-ambulance: a score comparison. Eur J Clin Invest. 2023; 53(1): e13875.
30	Kennedy C, Alqudah Z, Stub D, Anderson D, Nehme Z. The effect of the COVID-19 pandemic on the incidence and survival outcomes of EMS-witnessed out-of-hospital cardiac arrest. Resuscitation. 2023; 187: 109770.

Parameters^a	Survivors (n=793)	Non-survivors (n=168)	P-value^b
Epidemiological variables
Sex at birth, female	327 (41.2)	68 (40.5)	0.924
Age, year	71.2±16.0	75.6±13.5	<0.001
Ambulance, advanced life support	437 (55.1)	124 (73.8)	<0.001
Nursing home, yes	139 (17.5)	48 (28.6)	0.001
Basal vital signs
Respiratory rate, breaths/min	26.5±9.0	28.5±11.0	0.026
Oxygen saturation, %	88.3±11.0	81.4±14.2	<0.001
Fraction of inspired oxygen, %	0.4±0.2	0.6±0.3	<0.001
SaO₂/FiO₂ ratio	378±97	330±111	<0.001
Systolic blood pressure, mmHg	139±32	125±39	<0.001
Diastolic blood pressure, mmHg	79±20	72±24	<0.001
Heart rate, beats/min	98.1±25.5	104.0±32.8	0.044
Temperature, °C	36.6±1.0	36.6±1.4	0.751
Glasgow Coma Scale, points	14.1±2.5	11.4±4.5	<0.001
Prehospital respiratory diagnosis			<0.001
Dyspnea	312 (39.3)	71 (42.3)
COPD	128 (16.1)	17 (10.1)
Respiratory infection	173 (21.8)	55 (32.7)
COVID-19	108 (13.6)	13 (7.7)
Asthma crisis	32 (4.0)	0 (0.0)
Others^c	40 (5.0)	12 (7.1)
Outcomes
Prehospital NIMV	133 (16.8)	56 (33.3)	<0.001
Prehospital IMV	47 (5.9)	50 (29.8)	<0.001
aCCI, points	6.1±3.3	7.5±3.3	<0.001
Inpatient	567 (71.6)	168 (100.0)	<0.001
ICU-admission	74 (9.3)	52 (31.0)	<0.001

Medications	Survivors (n=793)	Non-survivors (n=168)	P-value^a
Anti-convulsant	6 (0.8)	1 (0.6)	0.998
Antiarrhythmic	10 (1.3)	4 (2.4)	0.284
Antibiotic	2 (0.3)	0 (0.0)	0.989
Antidote	10 (1.3)	7 (4.2)	0.018
Antiemetic	41 (5.2)	14 (8.3)	0.155
Antihypertensive	16 (2.0)	2 (1.2)	0.754
Antiplatelet agent	3 (0.4)	3 (1.8)	0.070
Anxiolytic	82 (10.4)	46 (27.4)	<0.001
Atropine	2 (0.3)	5 (3.0)	0.002
Beta-2-agonist (inhaled)	424 (53.5)	85 (50.6)	0.553
Beta-blocker	7 (0.9)	3 (1.8)	0.392
Bicarbonate	6 (0.8)	16 (9.5)	<0.001
Diuretic	183 (23.1)	34 (20.2)	0.485
Epinephrine	10 (1.3)	10 (6.0)	0.001
Fibrinolytic	0 (0.0)	3 (1.8)	0.005
Glucocorticoid	418 (52.7)	88 (52.4)	0.997
Glucocorticoid (inhaled)	231 (29.1)	44 (26.2)	0.502
Glucose 50%	6 (0.8)	5 (3.0)	0.029
Heparin	10 (1.3)	7 (4.2)	0.018
Hypnotics	40 (5.0)	47 (28.0)	<0.001
Insulin	31 (3.9)	11 (6.6)	0.190
Ions	14 (1.8)	5 (3.0)	0.354
Ipratropium bromide (inhaled)	403 (50.8)	70 (41.6)	0.031
Major analgesics	159 (20.1)	83 (49.4)	<0.001
Minor analgesics	206 (26.2)	51 (30.4)	0.311
Neuromuscular blocking agent	23 (2.9)	23 (13.7)	<0.001
Nitro-glycerine	67 (8.5)	11 (6.6)	0.507
Norepinephrine	11 (1.3)	17 (10.1)	<0.001
Proton pump inhibitor	60 (7.6)	11 (6.6)	0.767
Tranexamic acid	3 (0.4)	1 (0.6)	0.537

Variables	Odds ratio (95% CI)	P-value
Age	1.03 (1.02-1.05)	<0.001
Systolic blood pressure	0.99 (0.98-0.99)	0.009
Glasgow Coma Scale	0.86 (0.82-0.90)	<0.001
Age-Charlson comorbidity index	1.08 (1.02-1.14)	0.017
Invasive mechanical ventilation	7.21 (3.97-13.1)	<0.001
Non-invasive mechanical ventilation	2.46 (1.66-3.63)	<0.001
Major analgesics	2.26 (1.56-3.27)	<0.001
Hypnotics	4.64 (2.44-8.98)	<0.001
Neuromuscular blocking agent	0.17 (0.06-0.45)	0.003
Bicarbonate	5.23 (1.96-15.5)	0.007

Variables	Odds ratio (95% CI)	P-value
Age	1.03 (1.02-1.06)	<0.001
Systolic blood pressure	0.99 (0.98-1.00)	0.004
Glasgow Coma Scale	0.81 (0.76-0.88)	<0.001
aCCI	1.09 (1.01-1.18)	0.026
Non-invasive mechanical ventilation	2.32 (1.39-3.90)	0.001
Major analgesics	2.06 (1.22-3.47)	0.007
Hypnotics	7.45 (2.90-20.76)	<0.001

[1]	Chao Gong, Shengyong Xu, Youlong Pan, Shigong Guo, Joseph Harold Walline, Xue Wang, Xin Lu, Shiyuan Yu, Mubing Qin, Huadong Zhu, Yanxia Gao, Yi Li. Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review [J]. World Journal of Emergency Medicine, 2025, 16(1): 18-27.
[2]	Johan L. van Nieuwkerk, M. Christien van der Linden, Rolf J. Verheul, Merel van Loon-van Gaalen, Marije Janmaat, Naomi van der Linden. The impact of prehospital blood sampling on the emergency department process of patients with chest pain: a pragmatic non-randomized controlled trial [J]. World Journal of Emergency Medicine, 2023, 14(4): 257-264.
[3]	Xinlei Wang, Yao Sun, Xiaoyu Ni, Shu Zhang. Development and validation of an emergency bloodstream infection score for predicting in-hospital mortality in patients with community-acquired bloodstream infections [J]. World Journal of Emergency Medicine, 2023, 14(4): 280-286.
[4]	Hai Hu, Ni Yao, Xiao-qin Lai. Factors related to early and rapid assessment of in-hospital mortality among older adult trauma patients in an earthquake [J]. World Journal of Emergency Medicine, 2022, 13(6): 425-432.
[5]	Ralph Bou Chebl, Nadim Kattouf, Mohamad Assaf, Saadeddine Haidar, Gilbert Abou Dagher, Sarah Abdul Nabi, Rana Bachir, Mazen El Sayed. Comparing the demographic data and outcomes of septic shock patients presenting to teaching or non-teaching metropolitan hospitals in the United States [J]. World Journal of Emergency Medicine, 2022, 13(6): 433-440.
[6]	Gui-ying Dong, Fei-fei Jin, Qi Huang, Chun-bo Wu, Ji-hong Zhu, Tian-bing Wang. Exploratory COVID-19 death risk score based on basic laboratory tests and physiological clinical measurements [J]. World Journal of Emergency Medicine, 2022, 13(6): 453-458.
[7]	Chun Zhao, Mei-yun Xin, Jing Li, Jin-fang Zhao, Yu-juan Wang, Wei Wang, Qian Gao, Jie Chen, Qi-wei Wang, You-peng Jin. Comparing the precision of the pSOFA and SIRS scores in predicting sepsis-related deaths among hospitalized children: a multi-center retrospective cohort study [J]. World Journal of Emergency Medicine, 2022, 13(4): 259-265.
[8]	David Vandroux, Thomas Aujoulat, Bernard-Alex Gaüzère, Bérénice Puech, Bertrand Guihard, Olivier Martinet. Predicting factors for the need of extracorporeal membrane oxygenation for suicide attempts by cardiac medication: a single-center cohort study [J]. World Journal of Emergency Medicine, 2022, 13(4): 283-289.
[9]	Hai Hu, Jing-yuan Jiang, Ni Yao. Comparison of different versions of the quick sequential organ failure assessment for predicting in-hospital mortality of sepsis patients: A retrospective observational study [J]. World Journal of Emergency Medicine, 2022, 13(2): 114-119.
[10]	Yu-qing Cui, Xian-fei Ding, Huo-yan Liang, Dong Wang, Xiao-juan Zhang, Li-feng Li, Quan-cheng Kan, Le-xin Wang, Tong-wen Sun. Efficacy and safety of low-dose corticosteroids for acute respiratory distress syndrome: A systematic review and meta-analysis [J]. World Journal of Emergency Medicine, 2021, 12(3): 207-213.
[11]	Wen Gao, Yu-ping Zhang, Jing-fen Jin. Poor outcomes of delirium in the intensive care units are amplified by increasing age: A retrospective cohort study [J]. World Journal of Emergency Medicine, 2021, 12(2): 117-123.
[12]	Hao-tian Chen, Jian-feng Xu, Xiao-xia Huang, Ni-ya Zhou, Yong-kui Wang, Yue Mao. Blood eosinophils and mortality in patients with acute respiratory distress syndrome: A propensity score matching analysis [J]. World Journal of Emergency Medicine, 2021, 12(2): 131-136.
[13]	Wei Guo, Lin-yu Ran, Ji-hong Zhu, Qing-gang Ge, Zhe Du, Fei-long Wang, Wei-bo Gao, Tian-bing Wang. Identifying critically ill patients at risk of death from coronavirus disease [J]. World Journal of Emergency Medicine, 2021, 12(1): 18-23.
[14]	Rui-xue Sun, Priscilla Song, Joseph Walline, He Wang, Ying-chun Xu, Hua-dong Zhu, Xue-zhong Yu, Jun Xu. Morbidity and mortality risk factors in emergency department patients with Acinetobacter baumannii bacteremia [J]. World Journal of Emergency Medicine, 2020, 11(3): 164-168.
[15]	Shao-hua Liu, Huo-yan Liang, Hong-yi Li, Xian-fei Ding, Tong-wen Sun, Jing Wang. Effect of low high-density lipoprotein levels on mortality of septic patients: A systematic review and meta-analysis of cohort studies [J]. World Journal of Emergency Medicine, 2020, 11(2): 109-116.